560 related articles for article (PubMed ID: 33679757)
1. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
Gianchecchi E; Delfino DV; Fierabracci A
Front Immunol; 2021; 12():616853. PubMed ID: 33679757
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.
Segerberg F; Lundtoft C; Reid S; Hjorton K; Leonard D; Nordmark G; Carlsten M; Hagberg N
Front Immunol; 2019; 10():2164. PubMed ID: 31572377
[TBL] [Abstract][Full Text] [Related]
3. Innate inflammation drives NK cell activation to impair Treg activity.
Dean JW; Peters LD; Fuhrman CA; Seay HR; Posgai AL; Stimpson SE; Brusko MA; Perry DJ; Yeh WI; Newby BN; Haller MJ; Muir AB; Atkinson MA; Mathews CE; Brusko TM
J Autoimmun; 2020 Mar; 108():102417. PubMed ID: 32035746
[TBL] [Abstract][Full Text] [Related]
4. The role of KIR positive NK cells in diseases and its importance in clinical intervention.
Dizaji Asl K; Velaei K; Rafat A; Tayefi Nasrabadi H; Movassaghpour AA; Mahdavi M; Nozad Charoudeh H
Int Immunopharmacol; 2021 Mar; 92():107361. PubMed ID: 33429335
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell education in human health and disease.
Boudreau JE; Hsu KC
Curr Opin Immunol; 2018 Feb; 50():102-111. PubMed ID: 29413815
[TBL] [Abstract][Full Text] [Related]
6. Significance of KIR like natural killer cell receptors in autoimmune disorders.
Agrawal S; Prakash S
Clin Immunol; 2020 Jul; 216():108449. PubMed ID: 32376502
[TBL] [Abstract][Full Text] [Related]
7. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
8. The Role of Natural Killer Cells in Autoimmune Diseases.
Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
Front Immunol; 2021; 12():622306. PubMed ID: 33717125
[TBL] [Abstract][Full Text] [Related]
9. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
[TBL] [Abstract][Full Text] [Related]
10. Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use.
Blunt MD; Khakoo SI
Int J Immunogenet; 2020 Feb; 47(1):1-12. PubMed ID: 31755661
[TBL] [Abstract][Full Text] [Related]
11. Innate immunity as the trigger of systemic autoimmune diseases.
Saferding V; Blüml S
J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
[TBL] [Abstract][Full Text] [Related]
12. NK Cells in Autoimmune Diseases: Protective or Pathogenic?
Liu M; Liang S; Zhang C
Front Immunol; 2021; 12():624687. PubMed ID: 33777006
[TBL] [Abstract][Full Text] [Related]
13. The immunobiology of mTOR in autoimmunity.
Suto T; Karonitsch T
J Autoimmun; 2020 Jun; 110():102373. PubMed ID: 31831256
[TBL] [Abstract][Full Text] [Related]
14. The aberrant expression of stimulatory and inhibitory killer immunoglobulin-like receptors in NK- and NKT-cells contributes to lupus.
Bai Y; Zhang Y; Yang Q; Hou Y; Hu N; Wang D; Sun H
Clin Lab; 2014; 60(5):717-27. PubMed ID: 24839813
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
17. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
Front Immunol; 2021; 12():660506. PubMed ID: 34093549
[TBL] [Abstract][Full Text] [Related]
18. Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus.
Schepis D; Gunnarsson I; Eloranta ML; Lampa J; Jacobson SH; Kärre K; Berg L
Immunology; 2009 Jan; 126(1):140-6. PubMed ID: 18564343
[TBL] [Abstract][Full Text] [Related]
19. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
20. The role of natural killer cells in autoimmune liver disease: a comprehensive review.
Hudspeth K; Pontarini E; Tentorio P; Cimino M; Donadon M; Torzilli G; Lugli E; Della Bella S; Gershwin ME; Mavilio D
J Autoimmun; 2013 Oct; 46():55-65. PubMed ID: 23880068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
